TCL Archive Phase II Imbruvica Trial Shows 47% of MCL Patients Alive at 27-Month Median Follow-up December 26, 2014
TCL Archive In Brief: Override Failure Would Leave Cancer Program With No Money or New Projects Of Any Kind January 23, 1976
TCL Archive Three Win Medals Of Science For Biology; Social Worker, Survivor, Wins. February 11, 2000